News & Events

News

All categories

Earnings

Press Release

All years

2020

2019

2018

2017

2016

2015

2014

Affimed Added to Russell 2000® Index

June 30, 2015

Affimed Announces Opening of US Operations and Key US- based Hires

June 23, 2015

AbCheck and Pierre Fabre Pharmaceuticals Enter Into Strategic Research Partnership

June 17, 2015

Affimed Announces Newly Formed Scientific Advisory Board

June 3, 2015

Affimed ASCO Data Demonstrate Consistent Potency of NK- Cell-Engaging Combination Therapy with Checkpoint Modulators

May 29, 2015

Affimed ASCO Data for the CD33/CD3-TandAb Program Demonstrate that CD33 and CD3 binding affinities correlate with potent T-cell activation and cytotoxicity

May 29, 2015

Affimed to Present at the Jefferies 2015 Healthcare Conference – New York

May 27, 2015

Affimed Completes TandAb Development Candidate Activities Meeting Amphivena’s and Janssen’s Criteria and Achieves Milestone Ahead of Schedule

May 24, 2015

Affimed Reports Financial Results for First Quarter 2015

May 21, 2015

Affimed to Present Data at ASCO to Highlight Potency of NK- Cell-Engaging Combination Therapy with Checkpoint Modulators

May 13, 2015

Events

All

Scientific

Investors

29May

ASCO 2020 Annual Meeting

May 29 - June 2, 2020 (TBD)

25Aug

Innate Killer Summit 2020

August 25 - July 26, 2020 (San Diego, USA)
Presenter: Joachim Koch

Webcasts
More events

We use cookies to give you the best experience on our website. By continuing to use it, you agree with it.